MORPHINE SULFATE in Canada
153 medicine records from 22 holders carry this name in the official sources. Collected on November 13, 2026.
Medicines, page 2
| Name | Holder | Status | Code |
|---|---|---|---|
| MORPHINE SULFATE INJECTION · SINGLE-USE AMPOULE · 15 MG per ML · SOLUTION | JUNO PHARMA CANADA INC. | authorised |
DIN
02561220DPD drug code
106421
|
| MORPHINE SULFATE INJECTION USP · 100 MG per 100 ML · SOLUTION | STERINOVA INC. | authorised |
DIN
02491931DPD drug code
98194
|
| MORPHINE SULFATE INJECTION USP · 10 MG per ML · SOLUTION | PFIZER CANADA ULC | cancelled |
DIN
00850322DPD drug code
12991
|
| MORPHINE SULFATE INJECTION USP · 15 MG per ML · SOLUTION | PFIZER CANADA ULC | cancelled |
DIN
00850330DPD drug code
12992
|
| MORPHINE SULFATE INJECTION USP · 2 MG per ML · LIQUID | SANDOZ CANADA INCORPORATED | authorised |
DIN
02242484DPD drug code
66221
|
| MORPHINE SULFATE INJECTION USP · 2 MG per ML · SOLUTION | PFIZER CANADA ULC | cancelled |
DIN
00850314DPD drug code
12990
|
| MORPHINE SULFATE INJECTION USP · 50 MG per 50 ML · SOLUTION | STERINOVA INC. | authorised |
DIN
02491885DPD drug code
98189
|
| MORPHINE SULFATE INJECTION, USP · PREFILLED SYRINGE · 10 MG per 1 ML · SOLUTION | FRESENIUS KABI CANADA LTD | authorised |
DIN
02488647DPD drug code
97874
|
| MORPHINE SULFATE INJECTION, USP · PREFILLED SYRINGE · 2 MG per 1 ML · SOLUTION | FRESENIUS KABI CANADA LTD | authorised |
DIN
02488620DPD drug code
97871
|
| MORPHINE SULFATE INJECTION, USP · PREFILLED SYRINGE · 4 MG per 1 ML · SOLUTION | FRESENIUS KABI CANADA LTD | authorised |
DIN
02488639DPD drug code
97872
|
| MORPHINE SULFATE INJECTION USP · PRESERVATIVE-FREE, SINGLE-USE · 1 MG per ML · SOLUTION | ICU MEDICAL CANADA INC | cancelled |
DIN
00636908DPD drug code
6871
|
| MORPHINE SULFATE INJECTION USP · PRESERVATIVE-FREE, SINGLE-USE · 5 MG per ML · SOLUTION | ICU MEDICAL CANADA INC | cancelled |
DIN
00649619DPD drug code
7136
|
| MORPHINE SULFATE INJECTION, USP · PRESERVATIVE-FREE, SINGLE-USE VIAL · 10 MG per 1 ML · SOLUTION | FRESENIUS KABI CANADA LTD | authorised |
DIN
02482746DPD drug code
97315
|
| MORPHINE SULFATE INJECTION, USP · PRESERVATIVE-FREE, SINGLE-USE VIAL · 2 MG per 1 ML · SOLUTION | FRESENIUS KABI CANADA LTD | authorised |
DIN
02482681DPD drug code
97311
|
| MORPHINE SULFATE INJECTION, USP · PRESERVATIVE-FREE, SINGLE-USE VIAL · 4 MG per 1 ML · SOLUTION | FRESENIUS KABI CANADA LTD | cancelled |
DIN
02482703DPD drug code
97312
|
| MORPHINE SULFATE INJECTION, USP · PRESERVATIVE-FREE, SINGLE-USE VIAL · 5 MG per 1 ML · SOLUTION | FRESENIUS KABI CANADA LTD | cancelled |
DIN
02482711DPD drug code
97313
|
| MORPHINE SULFATE INJECTION, USP · PRESERVATIVE-FREE, SINGLE-USE VIAL · 8 MG per 1 ML · SOLUTION | FRESENIUS KABI CANADA LTD | cancelled |
DIN
02482738DPD drug code
97314
|
| MORPHINE SULPHATE INJ 1MG/ML BP · 1 MG per ML · LIQUID | DAVID BULL LABORATORIES (CANADA) INC. | cancelled |
DIN
00885509DPD drug code
14472
|
| MORPHINE SULPHATE INJECTION 1MG/ML · 1 MG per ML · LIQUID | HOSPIRA HEALTHCARE ULC | cancelled |
DIN
02137232DPD drug code
31285
|
| MORPHINE SULPHATE INJECTION 2MG/ML · 2 MG per ML · LIQUID | HOSPIRA HEALTHCARE ULC | cancelled |
DIN
02137240DPD drug code
31286
|
| MORPHINE SULPHATE INJECTION 50MG/ML · 50 MG per ML · LIQUID | HOSPIRA HEALTHCARE ULC | cancelled |
DIN
02137267DPD drug code
31288
|
| MORPHINE SULPHATE INJECTION B.P. 25MG/ML · 25 MG per ML · LIQUID | DAVID BULL LABORATORIES (CANADA) INC. | cancelled |
DIN
02022672DPD drug code
15941
|
| MORPHINE SULPHATE INJECTION BP 2MG/ML · 2 MG per ML · LIQUID | DAVID BULL LABORATORIES (CANADA) INC. | cancelled |
DIN
02003759DPD drug code
14524
|
| MORPHINE SULPHATE INJECTION B.P. 50MG/ML · 50 MG per ML · LIQUID | DAVID BULL LABORATORIES (CANADA) INC. | cancelled |
DIN
02022680DPD drug code
17139
|
| MORPHINE SULPHATE INJECTION, USP · 25 MG per ML · LIQUID | INTERNATIONAL MEDICATION SYSTEMS LTD. | cancelled |
DIN
02010380DPD drug code
13913
|
| MORPHINE SULPHATE INJECTION,USP LIQ 1.1MG/ML · 1.1 MG per ML · LIQUID | INTERNATIONAL MEDICATION SYSTEMS LTD. | cancelled |
DIN
02010364DPD drug code
14099
|
| MORPHINE SULPHATE INJECTION, USP LIQ50MG/ML · 50 MG per ML · LIQUID | INTERNATIONAL MEDICATION SYSTEMS LTD. | cancelled |
DIN
02009897DPD drug code
13905
|
| M.O.S. SULPHATE 10MG TAB · 10 MG · TABLET | VALEANT CANADA LP / VALEANT CANADA S.E.C. | cancelled |
DIN
02009765DPD drug code
14110
|
| M.O.S. SULPHATE 25MG TAB · 25 MG · TABLET | VALEANT CANADA LP / VALEANT CANADA S.E.C. | cancelled |
DIN
02009749DPD drug code
14107
|
| M.O.S. SULPHATE 50MG TAB · 50 MG · TABLET | VALEANT CANADA LP / VALEANT CANADA S.E.C. | cancelled |
DIN
02009706DPD drug code
14108
|
| M.O.S. SULPHATE 5MG TAB · 5 MG · TABLET | VALEANT CANADA LP / VALEANT CANADA S.E.C. | cancelled |
DIN
02009773DPD drug code
14111
|
| MS CONTIN · 100 MG · TABLET (EXTENDED-RELEASE) | PURDUE PHARMA | authorised |
DIN
02014319DPD drug code
14178
|
| MS CONTIN · 15 MG · TABLET (EXTENDED-RELEASE) | PURDUE PHARMA | authorised |
DIN
02015439DPD drug code
14395
|
| MS CONTIN · 200 MG · TABLET (EXTENDED-RELEASE) | PURDUE PHARMA | authorised |
DIN
02014327DPD drug code
14142
|
| MS CONTIN · 30 MG · TABLET (EXTENDED-RELEASE) | PURDUE PHARMA | authorised |
DIN
02014297DPD drug code
14176
|
| MS CONTIN · 60 MG · TABLET (EXTENDED-RELEASE) | PURDUE PHARMA | authorised |
DIN
02014300DPD drug code
14394
|
| MS CONTIN SUPPOSITORIES - 100MG · 100 MG per SUP · SUPPOSITORY (SUSTAINED-RELEASE) | PURDUE PHARMA | cancelled |
DIN
02145952DPD drug code
18562
|
| MS CONTIN SUPPOSITORIES - 200MG · 200 MG per SUP · SUPPOSITORY (SUSTAINED-RELEASE) | PURDUE PHARMA | cancelled |
DIN
02145960DPD drug code
18561
|
| MS CONTIN SUPPOSITORIES - 30MG · 30 MG per SUP · SUPPOSITORY (SUSTAINED-RELEASE) | PURDUE PHARMA | cancelled |
DIN
02146827DPD drug code
18557
|
| MS CONTIN SUPPOSITORIES - 60MG · 60 MG per SUP · SUPPOSITORY (SUSTAINED-RELEASE) | PURDUE PHARMA | cancelled |
DIN
02145944DPD drug code
18563
|
| MS CONTIN TABLETS · 5 MG per TAB · TABLET (EXTENDED-RELEASE) | PURDUE PHARMA | cancelled |
DIN
02229420DPD drug code
47228
|
| MS CONTIN XL CAPSULES · 120 MG per SRC · CAPSULE (SUSTAINED-RELEASE) | PURDUE PHARMA | cancelled |
DIN
02242830DPD drug code
66658
|
| MS CONTIN XL CAPSULES · 150 MG per SRC · CAPSULE (SUSTAINED-RELEASE) | PURDUE PHARMA | cancelled |
DIN
02242831DPD drug code
66659
|
| MS CONTIN XL CAPSULES · 200 MG per SRC · CAPSULE (SUSTAINED-RELEASE) | PURDUE PHARMA | cancelled |
DIN
02242832DPD drug code
66660
|
| MS CONTIN XL CAPSULES · 30 MG per SRC · CAPSULE (SUSTAINED-RELEASE) | PURDUE PHARMA | cancelled |
DIN
02242827DPD drug code
66655
|
| MS CONTIN XL CAPSULES · 60 MG per SRC · CAPSULE (SUSTAINED-RELEASE) | PURDUE PHARMA | cancelled |
DIN
02242828DPD drug code
66656
|
| MS CONTIN XL CAPSULES · 90 MG per SRC · CAPSULE (SUSTAINED-RELEASE) | PURDUE PHARMA | cancelled |
DIN
02242829DPD drug code
66657
|
| MS.IR · 10 MG · TABLET (IMMEDIATE-RELEASE) | PURDUE PHARMA | authorised |
DIN
02014211DPD drug code
14144
|
| MS.IR · 20 MG · TABLET (IMMEDIATE-RELEASE) | PURDUE PHARMA | authorised |
DIN
02014238DPD drug code
16480
|
| MS.IR · 30 MG · TABLET (IMMEDIATE-RELEASE) | PURDUE PHARMA | authorised |
DIN
02014254DPD drug code
16481
|
Need this list in your own system?
Every record on this page is available through the API, with its source, licence and retrieval date.